Hypofractionated stereotactic radiotherapy for the treatment of brain metastases

Cancer

Volumn 115, Issue 4, 2009, Pages 890-898

  Kwon, Alexander K ^a   Dibiase, Steven J ^a,c   Wang, Brian ^b   Hughes, Samuel L ^a   Milcarek, Barry ^a   Zhu, Yunping ^a  

^a Department of Anesthesiology   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c Delaware Valley Urology Cancer Treatment Center   (United States)

Author keywords

Brain metastasis; Hypofractionation; Stereotactic radiosurgery; Stereotactic radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVERSE OUTCOME; ARTICLE; BRAIN METASTASIS; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RADIATION RESPONSE; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; SURVIVAL TIME; TREATMENT RESPONSE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; BRAIN NEOPLASMS; CRANIAL IRRADIATION; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 60849112569     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24082     Document Type: Article

References (19)

1. Soffietti R, Costanza A, Laguzzi E, et al. Radiotherapy and chemotherapy of brain metastases. J Neurooncol. 2005;75:31-42.
2. Richards GM, Khuntia D, Mehta MP. Therapeutic management of metastatic brain tumors. Crit Rev Oncol Hematol. 2007;61:70-78.
3. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with 1 to 3 brain metastases: phase III results of the RTOG 9508 randomized trial. Lancet. 2004; 363:1665-1672.
4. Kamath R, Ryken TC, Meeks SL, et al. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases. Int J Radiat Oncol Biol Phys. 2005;61:1467-1472.
5. Hall EJ, Brenner DJ. The radiobiology of radiosurgery: rationale for different treatment regimes for AVMs and malignancies. Int J Radiat Oncol Biol Phys. 1993;25:381-385.
6. Manning MA, Cardinale RM, Benedict SH, et al. Hypo-fractionated stereotactic radiotherapy as an alternative to radiosurgery for the treatment of patients with brain metastases. Int J Radiat Oncol Biol Phys. 2000;47:603-608.
7. Aoki M, Abe Y, Hatayama Y, et al. Clinical outcome of hypofractionated conventional conformation radiotherapy for patients with single and no more than 3 metastatic brain tumors, with noninvasive fixation of the skull without whole brain irradiation. Int J Radiat Oncol Biol Phys. 2006;64:414-418.
8. Lindvall P, Bergstrom P, Lofroth P, et al. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. Int J Radiat Oncol Biol Phys. 2005;61:1460-1466.
9. Gaspar L, Scott C, Rotman M, et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys. 1997;37:745-751.
10. MacDonald DR, Cascino TL, Schold SC, et al. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol. 1990;8:1277-1280.
11. Kondziolka D, Patel A, Lunsford LD, et al. Stereotactic radiosurgery plus whole brain radiotherapy versus radiotherapy alone for patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;45:427-434.
12. Ernst-Stecken A, Ganslandt O, Lambrecht U, et al. Phase II trial of hypofractionated stereotactic radiotherapy for brain metastases: results and toxicity. Radiother Oncol. 2006;81:18-24.
13. Schomas DA, Roeske JC, MacDonald RL, et al. Predictors of tumor control in patients treated with linac-based stereo- tactic radiosurgery for metastatic disease to the brain. Am J Clin Oncol. 2005;28:180-187.
14. Varlotto JM, Flickinger JC, Niranjan A, et al. Analysis of tumor control and toxicity in patients who have survived at least 1 year after radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys. 2003;57:452-464.
15. Aoyama H, Shirato H, Onimaru R, et al. Hypofractionated stereotactic radiotherapy alone without whole-brain irradiation for patients with solitary and oligo brain metastasis using noninvasive fixation of the skull. Int J Radiat Oncol Biol Phys. 2003;56:793-800.
16. Shepherd SF, Laing RW, Cosgrove VP, et al. Hypofractionated stereotactic radiotherapy in the management of recurrent glioma. Int J Radiat Oncol Biol Phys. 1997;43:291-298.
17. Shaw M, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int JRadiat Oncol Biol Phys. 2000;47:291-298.
18. Vordermark D, Kolbl O, Ruprecht K, et al. Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC Cancer. 2005;5:55.
19. Manon R, O'Neill A, Knisely J, et al. Phase II trial of radiosurgery for 1 to 3 newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397). J Clin Oncol. 2005;23:8870-8876.